From August 21 to 22, the Beijing Oncology Clinical Research Forum 2026 and Hope Summit, hosted by Beijing Science and Technology Innovation Medical Development Foundation and undertaken by Peking University Cancer Hospital, was held at the Conference Center of Beijing Zhongguancun National Independent Innovation Demonstration Zone.

Since its inaugural session in 2023, the conference has evolved over four years into an important platform of international influence for innovation‑oriented exchanges in oncology clinical research. Bringing together 200 domestic and international industry administrators, clinical research experts and scholars, as well as industry representatives, this forum enabled in‑depth discussions with nearly 600 participants.

At the main forum session, Professor Thorvardu R. Halfdanarson from Mayo Clinic, Professor Kong Xiangrong from the Johns Hopkins University School of Medicine, Professor Song Yuqin, Vice President of Peking University Cancer Hospital, Professor Yan Fangrong from China Pharmaceutical University, and two industry representatives delivered presentations respectively.

The forum also drew participation from dozens of medical institutions across the country for exchanges and on‑site observation.

Written by: Wu Zhaoxia

Edited by: LiuXin

Source: Peking University Cancer Hospital